Navigation Links
PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage
Date:4/21/2009

WASHINGTON, April 21 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the national consumer health organization Families USA today unveiled a campaign to promote three key policies designed to help achieve high-quality, affordable health coverage for all Americans.

PhRMA and Families USA will work together and will reach out to other stakeholders to ensure that these policies are incorporated in the healthcare reform proposals to be considered this year. The two groups' efforts will include an advertising campaign and grassroots mobilization.

"Although our views do not always converge, we share a common belief about a fundamental goal of healthcare reform: Every American deserves high-quality, affordable health coverage and care," said PhRMA President and CEO Billy Tauzin and Families USA Executive Director Ron Pollack.

With this goal in mind, PhRMA and Families USA have partnered together to promote three essential elements of healthcare reform.

First, the two organizations will promote the establishment of a nationwide Medicaid eligibility floor at 133 percent of the federal poverty level -- almost $24,400 in annual income for a family of three. In 43 states, childless adults are currently ineligible for Medicaid even if they are literally penniless.

Second, we propose providing sliding-scale subsidies to moderate-income people who earn too much money to qualify for Medicaid but can't afford insurance premiums. Such subsidies are crucial for the purchase of healthcare in a reformed insurance market. A similar system exists today in Massachusetts.

Third, PhRMA and Families USA will seek a meaningful cap on out-of-pocket health expenditures so that no family is unable to afford essential care. This will also protect families against bankruptcy due to their need for major care.

In tandem with t
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America; Families USA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Families Embrace Science/Technology-based Ancestry Tracing Marking Milestone in Black Family Reunion Celebrations Across the Nation
2. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
3. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
4. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
5. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
6. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
7. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
8. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
9. Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
10. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
11. Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sia/--NODPharmaceuticalsInc.announced,theUSPatent&...tionfor,itsnano-particleoraldeliveryorNODtechnolog...oincorporatepeptidesor,proteinsintobio-adhesivenan...ministeredasinjections.NODtechnologyisaplatformtec...uchasinsulin,interferon,growthhormone,exenatide,h...
(Date:11/24/2009)...BlueMarbleEnergyCorp.announcedtodaythatthecompanya...entlyawarded$2millionbyWashingtonState,sCommunityE...artnershiptoconstructthestate,sfirstspecialtybioch...vestmentwillsignificantlyspeedthedevelopmentofourb...saidBlueMarbleEnergyCEOKellyOgilvie."Wearegrateful...
(Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(...iderofadvancedlasersystemsandinstrumentsforthestem...doperationalandfinancialresultsforthethirdquartere...uewas$1.46millioncomparedwith$1.43millioninQ32008,...rcentinQ3,2008,-Netlossreducedto$148,000comparedto...
(Date:11/24/2009)...Newswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GH...ecutiveChairman,willpresentatthe21stAnnualPiperJaf...ember1,2009at10:00a.m.ET. ,, Toaccesstheliveand...theInvestorRelationssectionofGenomicHealth,swebsit...cttothewebsiteatleast15minutespriortothebeginningo...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ennerex, Inc. today announced,the addition of Mr. ...n and,to The President & CEO, and the hiring of Mr...te Strategy. Bob Ingram is Vice Chairman, Pharmac...erved as Chief Executive Officer, Chief Operating ... for Glaxo Wellcome. Mr. Ingram,is Chairman of the...
...) and Abraxane(R) Show Promising Early Clinical ...EIGHTS, N.J., Nov. 8 Genta,Incorporated (Nasdaq: ...al,data using the Company,s lead oncology drug, Ge...ation with Abraxane(R) (paclitaxel protein-bound,p...; Abraxis BioScience,Inc.) and Temodar(R) (temozol...
...v. 7 Threshold,Pharmaceuticals, Inc. (Nasdaq: TH...rd quarter ended September 30, 2007. Net loss for ...d to $16.7 million for the third quarter of,2006. ...xia-activated prodrug,platform for the treatment o...osfamide," said Barry Selick, Threshold,s chief ex...
Other Biology Technology:Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 2Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 3Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium 4Threshold Pharmaceuticals Reports Third Quarter 2007 Financial Results 2Threshold Pharmaceuticals Reports Third Quarter 2007 Financial Results 3Threshold Pharmaceuticals Reports Third Quarter 2007 Financial Results 4Threshold Pharmaceuticals Reports Third Quarter 2007 Financial Results 5
(Date:11/25/2009)...ptember 11, firefighters, police officers and ambu...the World Trade Center complex. They battled to sa...d for survivors, tackled fires and evacuated as ma... an estimated 17,000 people. And making their jobs...s: frightened workers and their relatives jammed m...
(Date:11/25/2009)...JOLLA, CAWhen you eat may be just as vital to your...Salk Institute for Biological Studies. Their exper...waning of thousands of genes in the liverthe body,...ood intake and not by the body,s circadian clock a...e determines the activity of a large number of gen...
(Date:11/24/2009)...s that keep weakened and flabby arteries from coll...onths, those stents are no longer needed -- once t...ary. Previously, doctors had no choice but to leav... Aviv University,s Department of Biomedical Engine...tform that carries drugs where they,re needed, the...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 1First Ever Christopher Reeve Day 289 25 09 29 to be Celebrated with Memorable Chicago Events 58114 2Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 1Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 58111 2Webinar Series Launches for Eye Care Personnel 58108 1Webinar Series Launches for Eye Care Personnel 58108 2Webinar Series Launches for Eye Care Personnel 58108 3Webinar Series Launches for Eye Care Personnel 58108 4
...sonal beliefs about inconclusive DNA testing for h...-related worry, and such beliefs are an especially...o leave the period of DNA-testing behind, reports ...ine , official journal of the American College of ... by Lippincott Williams & Wilkins, a part of Wolte...
...gineers long have known that great ideas can be li...rchers at Yale University and the National Institu...a cellular level. Applying modern engineering desi...rgue that artificial cells could be built that not...c eel cells but in fact improve on them. Artificia...
... most comprehensive geological review ever underta...ombination of rising seas and dammed rivers could ... or more bays from Alabama to Texas. , "In terms ... into the bays, we,re rapidly approaching a time w... Holocene, from about 9,600 until 7,000 years ago,...
Other Biology News:Study looks at psychological impact of gene test for breast cancer 2Study looks at psychological impact of gene test for breast cancer 3Models of eel cells suggest electrifying possibilities 2Bays on US Gulf Coast vulnerable to flooding 2
...II (eIF4E-binding protein II) is involved in trans... kidney. PHAS proteins bind to eIF-4E, the mRNA ca...ed mRNA in vitro and in cells. Phosphorylation in ...HAS/eIF-4E complexes. This allows eIF-4E to bind t...
Human GCP-2, Unconjugated from CHEMICON
Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich
Mouse Anti-IgG2 (Fc, gamma-2 epitope) Monoclonal Antibody, Unconjugated, Clone 52G1 from Meridian Life Science, Inc.
Biology Products: